1 earlier Form 4 trade (code P or S) here by this insider (1 buy), the last on Jan 22, 2025.
3 other insiders sold within 30 days.
Insider activity: Insider GILLEN FRANK sold about $787.9K of MYCB on Jun 17, 2025, the largest insider sale at the company on our record; 3 other insiders sold within 30 days.
1 earlier Form 4 trade (code P or S) here by this insider (1 buy), the last on Jan 22, 2025.
The trade is 100.0% of the 5,249,513 shares held after it.
3 other insiders sold within 30 days.
Insider activity: Chief Executive Officer Goodell Yolanda sold about $787.4K of MYCB on Jun 17, 2025, the largest insider sale at the company on our record; 3 other insiders sold within 30 days.
1 earlier Form 4 trade (code P or S) here by this insider (1 buy), the last on Jan 22, 2025.
The trade is 100.0% of the 5,249,513 shares held after it.
3 other insiders sold within 30 days.
Insider activity: Chief Financial Officer Pittilloni Francis sold about $787.4K of MYCB on Jun 17, 2025, the largest insider sale at the company on our record; 3 other insiders sold within 30 days.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
3 other insiders sold within 30 days.
Insider activity: Insider Gonzalez Romero Jose Maria Eduardo sold about $42.2K of MYCB on Jun 17, 2025, the largest insider sale at the company on our record; 3 other insiders sold within 30 days.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 27.2% of the 5,252,714 shares held after it.
2 other insiders bought within 30 days.
Insider activity: Insider GILLEN FRANK bought about $572.0K of MYCB on Jan 22, 2025, the largest insider purchase at the company on our record; 2 other insiders bought within 30 days.
7 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
-$90.2K
four quarters, 2025-05-01 to 2026-04-30
Revenue, TTM MYCB
FY Jul 2025
$0
FY Jul 2024
$59.3K
FY Jul 2023
$49.2K
FY Jul 2022
$0
FY Jul 2021
$0
Apr 2026
$0
Jan 2026
$0
Oct 2025
$0
Jul 2025
-$90.2K
Apr 2025
$35.0K
Jan 2025
$29.7K
Oct 2024
$25.5K
Jul 2024
$23.7K
At each fiscal year end
Single quarter
Net margin, TTM
n/a
revenue under $1M, the ratio says nothing
Net margin, TTM MYCB
FY Jul 2025
n/a
FY Jul 2024
n/a
FY Jul 2023
n/a
FY Jul 2022
n/a
FY Jul 2021
n/a
Apr 2026
n/a
Jan 2026
n/a
Oct 2025
n/a
Jul 2025
n/a
Apr 2025
n/a
Jan 2025
n/a
Oct 2024
n/a
Jul 2024
n/a
At each fiscal year end
Single quarter
Free cash flow, TTM
n/a
capex not filed for the four quarters
Free cash flow, TTM MYCB
FY Jul 2025
n/a
FY Jul 2024
n/a
FY Jul 2023
n/a
FY Jul 2022
n/a
FY Jul 2021
n/a
Apr 2026
-$16.3K
Jan 2026
n/a
Oct 2025
n/a
Jul 2025
$139.5K
Apr 2025
-$305.6K
Jan 2025
n/a
Oct 2024
n/a
Jul 2024
-$310.7K
At each fiscal year end
Single quarter
Debt to equity
n/a
equity is zero or negative, the ratio has no meaning
Debt to equity MYCB
FY Jul 2025
301.82x
FY Jul 2024
1.18x
FY Jul 2023
n/a
FY Jul 2022
n/a
FY Jul 2021
n/a
Apr 2026
n/a
Jan 2026
n/a
Oct 2025
n/a
Jul 2025
301.82x
Apr 2025
0.51x
Jan 2025
0.58x
Oct 2024
1.45x
Jul 2024
1.18x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.06x
TTM operating cash flow over long-term 2025-04-30 (12 months older than the period end) plus current 2025-04-30 (12 months older than the period end)
Cash flow to debt MYCB
FY Jul 2025
-0.37x
FY Jul 2024
-0.35x
FY Jul 2023
n/a
FY Jul 2022
n/a
FY Jul 2021
-0.00x
Apr 2026
0.06x
Jan 2026
-0.10x
Oct 2025
-0.26x
Jul 2025
-0.37x
Apr 2025
-0.71x
Jan 2025
-0.51x
Oct 2024
-0.38x
Jul 2024
-0.35x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
-30.5%
TTM net income over average of 2025-04-30 and 2026-04-30
Return on equity MYCB
FY Jul 2025
-85.5%
FY Jul 2024
n/a
FY Jul 2023
n/a
FY Jul 2022
n/a
FY Jul 2021
n/a
Apr 2026
-30.5%
Jan 2026
-32.4%
Oct 2025
-86.1%
Jul 2025
-85.5%
Apr 2025
n/a
Jan 2025
n/a
Oct 2024
n/a
Jul 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
-17.1%
TTM net income over average of 2025-04-30 and 2026-04-30
Return on assets MYCB
FY Jul 2025
-28.4%
FY Jul 2024
n/a
FY Jul 2023
-156.4%
FY Jul 2022
n/a
FY Jul 2021
-12,283%
Apr 2026
-17.1%
Jan 2026
-20.1%
Oct 2025
-22.5%
Jul 2025
-28.4%
Apr 2025
n/a
Jan 2025
n/a
Oct 2024
n/a
Jul 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
pre-tax loss, no effective tax rate to apply
Return on invested capital MYCB
FY Jul 2025
n/a
FY Jul 2024
n/a
FY Jul 2023
n/a
FY Jul 2022
n/a
FY Jul 2021
n/a
Apr 2026
n/a
Jan 2026
n/a
Oct 2025
n/a
Jul 2025
n/a
Apr 2025
n/a
Jan 2025
n/a
Oct 2024
n/a
Jul 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
-5.2%
operating income (EBIT proxy) over average of 2025-04-30 and 2026-04-30 minus current liabilities
Return on capital employed MYCB
FY Jul 2025
-10.9%
FY Jul 2024
-173.9%
FY Jul 2023
n/a
FY Jul 2022
n/a
FY Jul 2021
n/a
Apr 2026
-5.2%
Jan 2026
-5.9%
Oct 2025
-9.2%
Jul 2025
-10.9%
Apr 2025
-2.7%
Jan 2025
-5.1%
Oct 2024
-104.4%
Jul 2024
-173.9%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
P/E, trailing MYCB
FY Jul 2025
n/a
FY Jul 2024
n/a
FY Jul 2023
n/a
FY Jul 2022
n/a
FY Jul 2021
n/a
Apr 2026
n/a
Jan 2026
n/a
Oct 2025
n/a
Jul 2025
n/a
Apr 2025
3.06x
Jan 2025
3.59x
Oct 2024
n/a
Jul 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$3.8M
market value at close 2026-10-26 on 2026-06-04 shares, plus long-term 2025-04-30 (12 months older than the period end) plus current 2025-04-30 (12 months older than the period end), minus cash 2022-04-30
Enterprise value MYCB
FY Jul 2025
$18.1M
FY Jul 2024
$7.6M
FY Jul 2023
$586.3K
FY Jul 2022
$298.0M
FY Jul 2021
$2.8M
Apr 2026
$3.3M
Jan 2026
$3.2M
Oct 2025
$15.2M
Jul 2025
$18.1M
Apr 2025
$12.3M
Jan 2025
$10.6M
Oct 2024
$5.5M
Jul 2024
$7.6M
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
capex not filed for the four quarters
FCF yield MYCB
FY Jul 2025
n/a
FY Jul 2024
n/a
FY Jul 2023
n/a
FY Jul 2022
n/a
FY Jul 2021
n/a
Apr 2026
n/a
Jan 2026
n/a
Oct 2025
n/a
Jul 2025
n/a
Apr 2025
n/a
Jan 2025
n/a
Oct 2024
n/a
Jul 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
PEG, trailing MYCB
FY Jul 2025
n/a
FY Jul 2024
n/a
FY Jul 2023
n/a
FY Jul 2022
n/a
FY Jul 2021
n/a
Apr 2026
n/a
Jan 2026
n/a
Oct 2025
n/a
Jul 2025
n/a
Apr 2025
n/a
Jan 2025
n/a
Oct 2024
n/a
Jul 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
MYCB ranks highest on risk and compliance (98th percentile) and financial health (38th), and lowest on profitability (15th), among Real Estate peers.
Profitability
15
Inputs
Return on equity-30.5% · 8 pct, sector of 230
Return on assets-17.1% · 5 pct, sector of 255
Return on invested capitalpre-tax loss, no effective tax rate to apply
Return on capital employed-5.2% · 33 pct, sector of 47
Financial health
38
Inputs
Debt to equityequity is zero or negative, the ratio has no meaning
Cash flow to debt0.06x · 38 pct, sector of 215
Risk and compliance
98
Inputs
Short interest, % of float+0.0% · 100 pct, sector of 258
Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
New text in Risk Factors, latest 10-K+2.1% · 95 pct, sector of 212
4 not measured: Growth, Insider conviction, Institutional and government, US patents
Growth needs 1 of 2 inputs, 0 present: no backlog line filed, or no year-earlier backlog; no revenue for this year and the year before
Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
3 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.